AI assistant
Sending…
CNS Pharmaceuticals, Inc. — Director's Dealing 2019
Nov 13, 2019
35399_dirs_2019-11-13_152a690b-5f4f-40e7-aac6-7406dafd9995.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CNS Pharmaceuticals, Inc. (CNSP)
CIK: 0001729427
Period of Report: 2019-11-13
Reporting Person: Downs Christopher (Chief Financial Officer)
More from CNS Pharmaceuticals, Inc.
Regulatory Filings
2026
May 26
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Board/Management Information
2026
Mar 2
Board/Management Information
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 2